论文部分内容阅读
目的探讨分析布地奈德混悬液联合氨溴索雾化吸入治疗毛细支气管炎的临床疗效。方法回顾性分析2010年2月至2013年5月在淇县人民医院进行治疗的250例毛细支气管炎患儿的临床资料。结果治疗后,治疗组的总有效率为92.8%,高于对照组的83.2%,差异有统计学意义(P<0.05);咳嗽等症状消失时间均明显短于对照组,差异有统计学意义(P<0.01)。结论布地奈德混悬液联合氨溴索雾化吸入治疗毛细支气管炎的临床疗效显著,具有推广价值。
Objective To investigate the clinical efficacy of budesonide suspension combined with ambroxol inhalation in the treatment of bronchiolitis. Methods The clinical data of 250 patients with bronchiolitis treated in Qixian People’s Hospital from February 2010 to May 2013 were retrospectively analyzed. Results After treatment, the total effective rate of the treatment group was 92.8%, which was higher than that of the control group (83.2%), the difference was statistically significant (P <0.05); the disappearance time of cough and other symptoms were significantly shorter than the control group, the difference was statistically significant (P <0.01). Conclusion The combination of budesonide suspension and ambroxol inhalation for the treatment of bronchiolitis has obvious curative effect and has the promotion value.